survodutide vs semaglutide Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research amino usa semaglutide Survodutide 6mg
Description
The drugs active ingredient, semaglutide, is a synthetic version of the GLP-1 (glucagon-like peptide-1) hormone, which the body naturally produces after eating
However, based on the Step 1 trial extension results, participants regained two-thirds of their prior weight loss after one year of withdrawal from weekly semaglutide injection and lifestyle interventions
This metabolic transition is reversible but realmost patients report increased appetite within 37 days of their last dose
At equivalent doses, most people eat similar amounts to Wegovy users
That combination is ideal for central fat loss
